Clinical trial Recruiting at 1 site Interventional Ages 25 to 45

Eccentric exercise with blood flow restriction versus heavy slow resistance for tennis elbow

Official title: Effectiveness of Eccentric Training With Blood Flow Restriction Therapy Versus Resistance Training in Patients With Lateral Epicondylitis

Run by University of Lahore · NCT07365033 · Data updated 2026-11-12

This study will see if adding blood flow restriction to eccentric wrist extensor exercises helps adults aged 25–45 with chronic lateral epicondylitis more than standard heavy slow resistance training.

Quick facts

Study typeInterventional
Ages25 Years to 45 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Lahore
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedJanuary 30, 2026
Main results expectedMarch 30, 2026
Study endsMarch 31, 2026
Registry record updatedFebruary 5, 2026
Trial IDNCT07365033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25–45 with unilateral chronic lateral epicondylitis lasting more than 12 months and positive Cozen's and Mill's tests who can attend supervised sessions are ideal candidates.

Probably not a fit

Patients with recent elbow surgery or injections, systemic inflammatory disease, vascular or clotting disorders, contraindications to blood flow restriction, pregnancy, uncontrolled hypertension, or bilateral symptoms are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-blinded randomized controlled trial will enroll 40 adults with chronic unilateral lateral epicondylitis and randomly assign them to either eccentric exercise with blood flow restriction (ECC+BFR) or heavy slow resistance (HSR) training. Each group will perform supervised sessions three times per week for eight weeks at participating hospitals in the Lahore region. Outcomes including pain intensity (NPRS), patient-specific functional performance (PSFS), muscle strength, and hypertrophy will be measured at baseline, 4 weeks, and 8 weeks. Data will be analyzed using appropriate parametric or nonparametric tests after checking normality.

Why it matters

Potential benefit: If successful, the ECC+BFR approach could reduce pain and improve function using lower loads, offering a more tolerable rehabilitation option for chronic tennis elbow.

How similar studies have gone: Blood flow restriction combined with low-load or eccentric exercise has shown promise in tendon and muscle rehabilitation in other conditions, but high-quality evidence specifically for lateral epicondylitis is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patient aged between 25 and 45 years. Both male and female participants with unilateral symptoms only. Clinically diagnosed unilateral lateral epicondylitis (LE), confirmed by positive Cozen's and Mills' tests. Symptom duration exceeding 12 months, indicating chronic LE.

Exclusion Criteria:

Previous history of surgery or injection therapy for LE within the past 6 months.

Coexisting conditions (e.g., rheumatoid arthritis, cervical radiculopathy, significant tendon tears). Contraindications to BFR (e.g., DVT, vascular disease, uncontrolled hypertension, clotting disorders).

Use of anticoagulants or long-term pain medications. Pregnant or psychological person.

Where it's running

  • University of Lahore Teaching Hospital, Lahore
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.